. 2018 Dec 28;52(4):302–306. doi: 10.14744/SEMB.2018.55376

Table 2.

Intergroup comparisons

	Groups

	Pemphigus– pemphigoid p	Pemphigus– control p	Pemphigoid– control p
HT	^a<0.01	^a0.84	^a<0.01
DM	^a<0.01	^a0.4	^a<0.01
CAD	^a0.008	^a0.86	^a0.001
Thyroid disease	^a0.87	^a0.34	^a0.51
Asthma	^a0.41	^a0.02	^a0.34
HL	^a0.87	^a0.98	^a0.86
Cataract	^a0.13	^a0.02	^a<0.01
Cholelithiasis	^a0.72	^a0.007	^a0.04
Appendectomy	^a0.13	^a0.03	^a0.59
Vitiligo	^a0.38	^a0.46	^a0.59
Malignancy	^a0.07	^a0.92	^a0.009
Depression	^a0.26	^a0.54	^a0.34
Dementia	^a0.11	^a1	^a0.008
Alzheimer	^a0.048	^a1	^a0.001
Parkinson	^a0.048	^a1	^a0.001
Psychosis	^a0.26	^a1	^a0.06
CVE	^a<0.01	^a0.39	^a<0.01
IBD	^a0.38	^a0.1	^a1
Parathyroid	^a0.38	^a0.8	^a0.45
BPH	^a0.11	^a0.04	^a0.54
Anemia	^a1	^a0.4	^a0.45
Skin cancer	^a1	^a0.29	^a0.35

Mann–Whitney U test; HT: Hypertension; DM: Diabetes mellitus; CAD: Coronary artery disease; HL: Hyperlipidemia; CVE: Cerebrovascular event; IBD: Inflammatory bowel disease; BPH: Benign prostatic hyperplasia